MedImmune Inc., the research and development arm of global drug giant AstraZeneca PLC, is spinning out a new company named Viela Bio with plans to create 100 jobs within the next three to five years.
{iframe}https://www.bizjournals.com/washington/news/2018/02/28/medimmune-announces-250-million-spinout-plan-to.html{/iframe}